| ULTI Stock | | | NOK 2.14 0.04 1.90% |
The current 90-days correlation between Ultimovacs ASA and Bergenbio ASA is 0.5 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ultimovacs ASA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ultimovacs ASA moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Ultimovacs ASA Correlation With Market
Significant diversification
The correlation between Ultimovacs ASA and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ultimovacs ASA and DJI in the same portfolio, assuming nothing else is changed.
The ability to find closely correlated positions to Ultimovacs ASA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ultimovacs ASA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ultimovacs ASA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ultimovacs ASA to buy it.
Moving together with Ultimovacs Stock
Moving against Ultimovacs Stock
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations | | High negative correlations |
Risk-Adjusted IndicatorsThere is a big difference between Ultimovacs Stock performing well and Ultimovacs ASA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ultimovacs ASA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ultimovacs ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
| | ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
Ultimovacs ASA Corporate Management
Elected by the shareholders, the Ultimovacs ASA's board of directors comprises two types of representatives: Ultimovacs ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ultimovacs. The board's role is to monitor Ultimovacs ASA's management team and ensure that shareholders' interests are well served. Ultimovacs ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ultimovacs ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.